It’s harvest day at the Karolinska Institute in Stockholm. As sunshine bathes the leafy university campus, scientists inside the labs work under cool fluorescent light. Clad in green protective gear, they tend meticulously to test tubes within hermetically sealed cleanrooms. The containers hold the fruits of today’s labour: mesenchymal stem cells (MSCs). Each cell is barely a quarter the width of a human hair but wields remarkable power. MSCs reduce inflammation, repair damaged tissue, and modulate the immune system. They can treat chronic diseases and delay ageing. They may even prevent illness before it begins. But to become a mainstay…This story continues at The Next Web [...]
Inflection AI, the Palo Alto startup that two years ago became Silicon Valley's most famous cautionary tale about the brutal economics of frontier AI, announced Tuesday that it is returning to th [...]
Bright Machines wants to solve one of the least glamorous but most consequential problems in the AI buildout: what happens to quality data when a human being has to touch the production line.The San F [...]
Novo will take an equity stake in Cellular Intelligence and is in line for future milestone payments and royalties. The startup plans to apply its AI platform to STEM-PD, a stem-cell-derived treatment [...]
Resolve AI, the production-operations startup backed by Greylock and Lightspeed Venture Partners, today announced a sweeping expansion of its platform that introduces always-on background agents, a re [...]